SG165370A1 - Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites - Google Patents
Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolitesInfo
- Publication number
- SG165370A1 SG165370A1 SG201006597-7A SG2010065977A SG165370A1 SG 165370 A1 SG165370 A1 SG 165370A1 SG 2010065977 A SG2010065977 A SG 2010065977A SG 165370 A1 SG165370 A1 SG 165370A1
- Authority
- SG
- Singapore
- Prior art keywords
- crc
- diagnosis
- present
- relates
- vitamin
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71631005P | 2005-09-12 | 2005-09-12 | |
| US80476406P | 2006-06-14 | 2006-06-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG165370A1 true SG165370A1 (en) | 2010-10-28 |
Family
ID=37865285
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012041315A SG182169A1 (en) | 2005-09-12 | 2006-09-12 | Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites |
| SG201006597-7A SG165370A1 (en) | 2005-09-12 | 2006-09-12 | Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012041315A SG182169A1 (en) | 2005-09-12 | 2006-09-12 | Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10697969B2 (fr) |
| EP (2) | EP1931995A4 (fr) |
| JP (1) | JP5038311B2 (fr) |
| KR (1) | KR20080049821A (fr) |
| AU (1) | AU2006291988B2 (fr) |
| CA (3) | CA2881326A1 (fr) |
| SG (2) | SG182169A1 (fr) |
| WO (1) | WO2007030928A2 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101479230A (zh) | 2006-05-26 | 2009-07-08 | 菲诺梅诺米发现公司 | 用于诊断多发性硬化的生物标记及其方法 |
| JP5746811B2 (ja) | 2006-12-21 | 2015-07-08 | 味の素株式会社 | 大腸癌の評価方法、ならびに大腸癌評価装置、大腸癌評価方法、大腸癌評価システム、大腸癌評価プログラムおよび記録媒体 |
| US20100086960A1 (en) * | 2007-02-01 | 2010-04-08 | Phenomenome Discoveries Inc. | Methods for the diagnosis of ovarian cancer health states and risk of ovarian cancer health states |
| AU2007346587C1 (en) | 2007-02-08 | 2015-01-22 | Med-Life Discoveries Lp | Methods for the treatment of Senile Dementia of the Alzheimer's Type |
| US8710429B2 (en) * | 2007-12-21 | 2014-04-29 | The Board Of Regents Of The University Of Ok | Identification of biomarkers in biological samples and methods of using same |
| US20120004854A1 (en) * | 2008-05-28 | 2012-01-05 | Georgia Tech Research Corporation | Metabolic biomarkers for ovarian cancer and methods of use thereof |
| EP2483697B2 (fr) | 2009-10-01 | 2017-07-05 | Phenomenome Discoveries Inc. | Méthode pour diagnostiquer le cancer du pancréas |
| PT2572193T (pt) | 2010-05-21 | 2018-01-31 | Univ Alberta | Métodos para a examinação de cancro colorretal e pólipos colorretais por medição de metabólitos na urina |
| US9141756B1 (en) | 2010-07-20 | 2015-09-22 | University Of Southern California | Multi-scale complex systems transdisciplinary analysis of response to therapy |
| JP2014526696A (ja) * | 2011-09-14 | 2014-10-06 | ビーエーエスエフ ソシエタス・ヨーロピア | 生殖腺毒性を評価するための手段及び方法 |
| US9689874B2 (en) | 2015-04-10 | 2017-06-27 | Applied Proteomics, Inc. | Protein biomarker panels for detecting colorectal cancer and advanced adenoma |
| US10006925B2 (en) | 2016-05-30 | 2018-06-26 | Universal Diagnostics, S. L. | Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps |
| US11073522B2 (en) | 2016-10-03 | 2021-07-27 | Lincoln Memorial University | Structural validation of very long chain dicarboxylic acids |
| US20180092874A1 (en) * | 2016-10-03 | 2018-04-05 | Lincoln Memorial University | Identification and use of very long chain dicarboxylic acids for disease diagnosis, chemoprevention, and treatment |
| KR20200020801A (ko) * | 2017-06-15 | 2020-02-26 | 메드-라이프 디스커버리즈 엘피 | 바이오시편에서의 수준을 정량화하기 위한 표준으로서의 디카르복실 지방산 이량체 및 이의 유도체 |
| US11840720B2 (en) | 2019-12-23 | 2023-12-12 | Metabolomic Technologies Inc. | Urinary metabolomic biomarkers for detecting colorectal cancer and polyps |
| CN114839298B (zh) * | 2019-12-28 | 2024-06-07 | 中精普康(北京)医药科技有限公司 | 一种用于检测结直肠癌或腺瘤的生物标志物及其方法 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4978852A (en) | 1988-09-08 | 1990-12-18 | Cornell Research Foundation, Inc. | Hadamard transform measurement of MSN Fourier-transform mass spectra |
| US4956788A (en) | 1988-11-28 | 1990-09-11 | University Of The Pacific | PC-based FT/ICR system |
| US5233190A (en) | 1990-03-16 | 1993-08-03 | Leybold Inficon Inc. | Fourier transform molecular spectrometer |
| US5538897A (en) | 1994-03-14 | 1996-07-23 | University Of Washington | Use of mass spectrometry fragmentation patterns of peptides to identify amino acid sequences in databases |
| US5668373A (en) | 1996-04-26 | 1997-09-16 | Trustees Of Tufts College | Methods and apparatus for analysis of complex mixtures |
| GB9617852D0 (en) | 1996-08-27 | 1996-10-09 | Univ Manchester Metropolitan | Micro-organism identification |
| GB9624927D0 (en) | 1996-11-29 | 1997-01-15 | Oxford Glycosciences Uk Ltd | Gels and their use |
| US6428956B1 (en) | 1998-03-02 | 2002-08-06 | Isis Pharmaceuticals, Inc. | Mass spectrometric methods for biomolecular screening |
| CA2339817A1 (fr) | 1998-08-12 | 2000-02-24 | Zycos Inc. | Etablissement de profil et catalogage de marqueurs de proteines exprimees |
| US20020009394A1 (en) | 1999-04-02 | 2002-01-24 | Hubert Koster | Automated process line |
| EP1688987A1 (fr) | 1999-04-06 | 2006-08-09 | Micromass UK Limited | Méthode pour l' identification de peptides et de protéines par spectrométrie de masse |
| US6489121B1 (en) | 1999-04-06 | 2002-12-03 | Micromass Limited | Methods of identifying peptides and proteins by mass spectrometry |
| WO2000063683A1 (fr) | 1999-04-20 | 2000-10-26 | Target Discovery, Inc. | Procedes de cartographie peptidique de polypeptides, etablissement de profils et systeme de base de donnees bioinformatique |
| US6677114B1 (en) | 1999-04-20 | 2004-01-13 | Target Discovery, Inc. | Polypeptide fingerprinting methods and bioinformatics database system |
| US6446010B1 (en) | 1999-06-15 | 2002-09-03 | The Rockefeller University | Method for assessing significance of protein identification |
| CA2298181C (fr) | 2000-02-02 | 2006-09-19 | Dayan Burke Goodnough | Analyse d'echantillons complexes non-cibles |
| JP2003521257A (ja) | 2000-02-07 | 2003-07-15 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | （ポリ）ペプチドを同定しおよび／または特性決定するための方法 |
| JP2003530130A (ja) | 2000-04-14 | 2003-10-14 | メタボロン インコーポレイテッド | メタボロミクスを使用した薬物発見、疾患の処置、及び診断のための方法 |
| US7329489B2 (en) | 2000-04-14 | 2008-02-12 | Matabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| EP1294923A2 (fr) | 2000-05-31 | 2003-03-26 | The Johns Hopkins University | Procedes d'utilisation de la spectrometrie de masse dans l'identification et la classification de champignons filamenteux, de levures, de moisissure et de pollen |
| SE517259C2 (sv) | 2000-06-14 | 2002-05-14 | Jan Eriksson | System för molekylidentifiering |
| US6680203B2 (en) * | 2000-07-10 | 2004-01-20 | Esperion Therapeutics, Inc. | Fourier transform mass spectrometry of complex biological samples |
| DE10100238A1 (de) | 2001-01-05 | 2002-08-22 | Hannover Med Hochschule | Verfahren zur Vorhersage des Gefährdungspotentials für Karzinomerkrankungen und entzündliche Darmerkrankungen und zugehörige Tests |
| EP1417629B1 (fr) | 2001-07-06 | 2008-02-20 | Lipomics Technologies, Inc. | Methodes permettant de generer, visualiser, interpreter et utiliser une base de donnees quantitatives de metabolites |
| CA2457437A1 (fr) * | 2001-08-03 | 2003-02-20 | Biotron Limited | Nouveau marqueur du cancer et ses utilisations dans le diagnostic du cancer |
| WO2003017177A2 (fr) | 2001-08-13 | 2003-02-27 | Beyong Genomics, Inc. | Procede et systeme pour l'etablissement de profils de systemes biologiques |
| US20030108876A1 (en) | 2001-12-11 | 2003-06-12 | Speir Johnny Paul | Method for the application of FTMS to drug testing |
| US7109038B2 (en) | 2002-06-13 | 2006-09-19 | The Johns Hopkins University | Occult blood detection in biological samples by laser desorption and matrix-assisted laser desorption/ionization mass spectrometry for biomedical applications |
| EP1895302A3 (fr) * | 2003-04-08 | 2008-05-14 | Colotech A/S | Procédé de détection d'un cancer colorectal dans des prélèvements humains |
| AU2004239417A1 (en) * | 2003-05-15 | 2004-11-25 | Europroteome Ag | Differential diagnosis of colorectal cancer and other diseases of the colon |
| EP1794322A4 (fr) | 2004-07-30 | 2009-10-28 | Sinai School Medicine | Formes alternatives d'epissure de klf6 et polymorphisme d'adn de klf6 de cellules germinales associes a un risque accru de cancer |
-
2006
- 2006-09-12 AU AU2006291988A patent/AU2006291988B2/en active Active
- 2006-09-12 CA CA2881326A patent/CA2881326A1/fr not_active Abandoned
- 2006-09-12 CA CA2772688A patent/CA2772688A1/fr not_active Abandoned
- 2006-09-12 EP EP06817639A patent/EP1931995A4/fr not_active Ceased
- 2006-09-12 KR KR1020087008798A patent/KR20080049821A/ko not_active Application Discontinuation
- 2006-09-12 SG SG2012041315A patent/SG182169A1/en unknown
- 2006-09-12 SG SG201006597-7A patent/SG165370A1/en unknown
- 2006-09-12 CA CA2619732A patent/CA2619732C/fr active Active
- 2006-09-12 JP JP2008529437A patent/JP5038311B2/ja active Active
- 2006-09-12 EP EP16187670.1A patent/EP3165925B1/fr active Active
- 2006-09-12 WO PCT/CA2006/001502 patent/WO2007030928A2/fr active Application Filing
-
2016
- 2016-06-24 US US15/192,522 patent/US10697969B2/en active Active
-
2020
- 2020-05-20 US US16/879,155 patent/US20210041444A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SG182169A1 (en) | 2012-07-30 |
| JP2009508091A (ja) | 2009-02-26 |
| US20210041444A1 (en) | 2021-02-11 |
| EP1931995A4 (fr) | 2010-08-04 |
| WO2007030928A2 (fr) | 2007-03-22 |
| US20160377622A1 (en) | 2016-12-29 |
| US10697969B2 (en) | 2020-06-30 |
| EP3165925B1 (fr) | 2021-09-08 |
| CA2619732A1 (fr) | 2007-03-22 |
| WO2007030928A8 (fr) | 2007-06-14 |
| EP1931995A2 (fr) | 2008-06-18 |
| JP5038311B2 (ja) | 2012-10-03 |
| KR20080049821A (ko) | 2008-06-04 |
| CA2772688A1 (fr) | 2007-03-22 |
| AU2006291988A1 (en) | 2007-03-22 |
| WO2007030928A3 (fr) | 2007-05-03 |
| EP3165925A1 (fr) | 2017-05-10 |
| CA2619732C (fr) | 2012-06-12 |
| CA2881326A1 (fr) | 2007-03-22 |
| AU2006291988B2 (en) | 2013-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG165370A1 (en) | Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites | |
| CY1120296T1 (el) | ΔΙΑΛΥΤΟΣ ΥΠΟΔΟΧΕΑΣ ΕΝΕΡΓΟΠΟΙΗΤΗ ΤΟΥ ΠΛΑΣΜΙΝΟΓΟΝΟΥ ΤΥΠΟΥ ΟΥΡΟΚΙΝΑΣΗΣ (suPAR) ΩΣ ΔΙΑΓΝΩΣΤΙΚΟΣ ΔΕΙΚΤΗΣ ΓΙΑ ΧΑΜΗΛΟΥ ΒΑΘΜΟΥ ΦΛΕΓΜΟΝΗ | |
| BRPI0720371B8 (pt) | métodos para diagnóstico ou monitoramento da progressão de câncer de próstata em um indivíduo e uso in vitro de pelo menos um homeodomínio contendo o fator de transcrição como um biomarcador para câncer de próstata | |
| EA200801046A1 (ru) | Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro | |
| WO2006089212A3 (fr) | Cyr61 comme biomarqueur pour le diagnostic et le pronostic de cancers d'origine epitheliale | |
| WO2012018535A3 (fr) | Panneau de bien-être | |
| WO2007030949A3 (fr) | Procedes de diagnostic de cancer des ovaires et necessaires a cet effet | |
| HK1128310A1 (en) | Method and apparatus for correlating levels of biomarker products with disease | |
| DE602006018578D1 (de) | Diagnose- und prognoseverfahren von blasenkrebs. | |
| MY184498A (en) | Methods for the diagnosis of ovarian cancer health states and risk of ovarian cancer health states | |
| WO2008135862A3 (fr) | Dispositifs et procédés pour détecter des analysats | |
| WO2012047899A3 (fr) | Nouveaux biomarqueurs de diagnostic de cancer colorectal par l'hyperméthylation de l'adn | |
| IL207637A (en) | Choosing a Breast Cancer Remedy Using Antibody-Based Arrays | |
| WO2005010486A3 (fr) | Groupe special de marquers biologiques pour cancer colorectal | |
| WO2007140352A3 (fr) | Membrane plasmatique et biomarqueurs de cancer sécrétés | |
| IN2013CN01129A (fr) | ||
| WO2008061149A3 (fr) | Procédés et compositions de diagnostic et de pronostic de la sténose d'artère rénale | |
| WO2007119111A3 (fr) | Diagnostics tissulaires pour cancer de l'ovaire | |
| WO2013057581A8 (fr) | Biomarqueurs composites pour criblage, diagnostic et pronostic non invasifs de cancer colorectal | |
| CA2701341A1 (fr) | Procede de detection du cancer colorectal a partir d'un echantillon de selles au moyen d'une combinaison de marqueurs associant la calprotectine et le complexe hemoglobine/haptoglobine | |
| CY1114386T1 (el) | Διαγνωση καρκινου του προστατη | |
| DE602005023629D1 (de) | Biomarker für den frühzeitigen nachweis von ovarialkarzinom | |
| WO2005071407A3 (fr) | Methodes | |
| MX339340B (es) | Metodos para predecir y mejorar la supervivencia de pacientes con cancer gastrico. | |
| WO2004021008A3 (fr) | Methodes de detection du cancer du sein et des ovaires |